Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopamine Infusion and Insulin Secretion in Healthy Subjects
NCT02053935Phase 1Completed
- Sponsor
- Albert Einstein College of Medicine
- Start
- Dec 2013
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label trial of dopamine in sepsis and hyperglycemia, sponsored by Albert Einstein College of Medicine. Primary endpoint: insulin secretion at 4 hours. Started Dec 2013; status: completed.
02
Drugs
dopamine
03
Conditions
sepsishyperglycemia
Beyond the preview
Go deeper on NCT02053935.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02053935.